Oprane
Oprane is a medicine authorised by Swissmedic under authorisation number 56250. The authorisation holder is OM Pharma Suisse SA. The medicinal product code is Herbal medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 30 September 2002 and the authorisation is valid without a time limit. ATC code G02CX03 places the medicine in the group Other gynecologicals.
| Authorisation number | 56250 |
|---|---|
| Name | Oprane |
| Full name | Oprane, comprimés pelliculés |
| Authorisation holder | OM Pharma Suisse SA |
| Medicinal product code | Herbal medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | G02CX03 |
| First authorisation | 30 September 2002 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Oprane, comprimés pelliculés | D | 30 September 2002 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 5 | 1 x 30 | Tablette(n) | G02CX03 | 09.99.0. | D |
| 19 | 3 x 30 | Tablette(n) | G02CX03 | 09.99.0. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Oprane authorised in Switzerland?
Yes. Oprane is authorised by Swissmedic under authorisation number 56250, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Oprane have?
Oprane is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Oprane?
The authorisation holder is OM Pharma Suisse SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.